Ventas, Inc.

NYSE:VTR

REIT - Healthcare Facilities

Real Estate
$88.20 -0.34%

-$0.28 today

Market cap
$46.64B
Beta
0.73
P/E (TTM)
149.7
EPS (TTM)
$0.55
Dividend yield
2.39%
52W Low $61.76High $91.06

Volume 3.72M

Average 4.09M

VTR Common Stock Issued

Cash raised by issuing new shares.

Ventas, Inc.NYSE: VTR

Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026

Common stock issued growth accelerates

Q2 FY2026 common stock issued of $1.75B rose 805.1% year over year, ahead of the +51.7% change in trailing-twelve-month common stock issued. Sequentially, it rose 115.3% from the prior quarter. Over 3 fiscal years it compounded at +555.9% a year.

Context

  • Common stock issued amounted to 42.0% of revenue in FY2025, up 1.7 pp from a year earlier.
  • Common stock issued increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +805.1% holds above the trailing-twelve-month pace of +51.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.75B+115.3% QoQ
Last fiscal yearDec 2025
$2.45B+23.3% YoY
LTMJun 2026
$3.93B+51.7% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+805.1%——
1 year+23.3%——
3-year CAGR+555.9%——
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
2.45B USD
Year-over-year change
+23.3%
4-year CAGR
+40.7%

Common Stock Issued vs competitors

How VTR compares with its peers on the latest reported figures

  • VTR's LTM Jun 2026 common stock issued of $3.93B is the 2nd largest of the 11 companies compared; the peer median is $245.29M.
  • Its year-over-year change of +51.7% is the 6th highest of 10, against a peer median of +105.1%.
  • Common stock issued amounts to 60.9% of revenue for VTR, versus a peer median of 24.6%.
VTR Competitors Peer median
Common Stock Issued for VTR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELLWelltower Inc.LTM Sep 2026$6.52B -27.5%+34.4%47.6%
VTRVentas, Inc.LTM Jun 2026$3.93B +51.7%+555.9%60.9%
AHRAmerican Healthcare REIT, Inc.LTM Sep 2026$2.97B +397.1%—111.2%
CTRECareTrust REIT, Inc.LTM Sep 2026$1.34B +26.8%—217.6%
OHIOmega Healthcare Investors, Inc.LTM Jun 2026$255.23M -82.7%+321.9%19.8%
SBRASabra Health Care REIT, Inc.LTM Jun 2026$251.28M +216.8%—29.2%
LTCLTC Properties, Inc.LTM Sep 2026$239.3M +214.5%—60.7%
NHINational Health Investors, Inc.LTM Sep 2026$91.54M -67.0%—20.0%
MPTMedical Properties Trust, Inc.LTM Jun 2026$3.52M +105.1%—0.3%
DOCHealthpeak Properties, Inc.LTM Sep 2026$1.58M +314.5%-84.5%0.1%
NHPNational Healthcare Properties, Inc. (NHP)LTM Dec 2025$0 ——0.0%
Peer median (excluding VTR) $245.29M+105.1%+34.4%24.6%

Competitors are the stored peer set for VTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income49.01M(47.45M)(40.97M)81.15M251.38M
Depreciation & Amortization978M1.09B1.17B1.17B1.38B
Deferred Income Tax00000
Stock-Based Compensation00000
Change in Working Capital(43.77M)(40.79M)(53.6M)43.81M49.43M
Accounts Receivables00000
Inventory00000
Accounts Payables16.72M7.2M(6.41M)133.97M81.04M
Other Working Capital(60.49M)(47.98M)(47.19M)(90.16M)(31.61M)
Other Non-Cash Items60.72M146.71M123.25M45.89M475K
Operating Cash Flow1.04B1.15B1.19B1.34B1.68B
Capital Expenditures(185.28M)(222.13M)(259.42M)(281.61M)(363.86M)
Acquisitions (Net)(22.49M)5.2M31.75M(7.36M)(1.98M)
Purchases of Investments(1.75B)(792.92M)(523.33M)(2.44B)(2.63B)
Sales of Investments1.19B113.82M494.22M335.96M261.98M
Other Investing Activities1.29M13.7M17.58M3.54M5.01M
Investing Cash Flow(764.48M)(882.33M)(239.2M)(2.39B)(2.73B)
Debt Repayment(447.96M)468.8M97.75M249.13M(670.52M)
Common Stock Issued625.61M8.69M109.06M1.99B2.45B
Common Stock Repurchased(96K)(1.49M)000
Dividends Paid(686.89M)(720.32M)(723.56M)(740.33M)(860.06M)
Other Financing Activities(26.64M)(44.82M)(47.13M)(44.73M)(45.94M)
Financing Cash Flow(535.97M)(289.13M)(563.88M)1.45B875.73M
Effect of Forex Changes1.45M(2.87M)1.26M(3.99M)2.84M
Net Change in Cash(255.04M)(25.85M)392.72M393.77M(171.1M)
Free Cash Flow858.69M926.34M935.13M1.06B1.32B

Ventas, Inc.

NYSE:VTR

Intrinsic Alpha fair value

Locked

Current Price

$88.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.